{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T23:57:19Z","timestamp":1770163039830,"version":"3.49.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["NSF\/MCB 016515"],"award-info":[{"award-number":["NSF\/MCB 016515"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES024478"],"award-info":[{"award-number":["R01ES024478"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01ES034253"],"award-info":[{"award-number":["R01ES034253"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["1R01ES036051-01"],"award-info":[{"award-number":["1R01ES036051-01"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA266078"],"award-info":[{"award-number":["CA266078"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Histones scaffold genomic DNA and regulate access to the transcriptional machinery. However, naturally occurring histone variants can alter histone-DNA interactions, DNA and histone modifications, and the chromatin interactome. Hence, alterations in histone variant deposition can disrupt chromatin, and are increasingly recognized as a way to trigger various disease, including cancer. While significant attention has been placed on the biochemical and functional roles of H2A, H3, and H4 histone variants, the variants of H2B remain largely understudied. Here, we show that H2B variants are dysregulated in breast cancer and that certain variants are associated with specific breast cancer subtypes.\n                    <jats:italic>HIST1H2BO<\/jats:italic>\n                    overexpression (in particular) is more common in Asian, African American\/Black, and young female populations and is associated with a worse prognosis. In vitro studies show that H2B1O compacts nucleosome structure. Incorporating H2B1O into chromatin activates pro-inflammatory and oncogenic pathways, induces epithelial-to-mesenchymal transition (EMT), and generates resistance to first-line chemotherapeutic agents. Thus, H2B1O acts much like an onco-histone, with H2B variant expression being a prognostic biomarker for breast cancer and a potential new target for drug therapies to enhance treatment efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s41388-025-03636-1","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:14:09Z","timestamp":1769249649000},"page":"669-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single amino-acid differences define H2B variants and modify chromatin accessibility to induce EMT in breast cancer"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8607-2222","authenticated-orcid":false,"given":"Hejer","family":"Dhahri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley N.","family":"Saintilnord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisson","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah N.","family":"Damico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9962-0108","authenticated-orcid":false,"given":"Youssef A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4350-2708","authenticated-orcid":false,"given":"Flavio R.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-0562","authenticated-orcid":false,"given":"Dani\u00ebl P.","family":"Melters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell P.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7655-6182","authenticated-orcid":false,"given":"Yamini","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-1369","authenticated-orcid":false,"given":"Jonathan D.","family":"Licht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-1428","authenticated-orcid":false,"given":"Marcelo G.","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-9920","authenticated-orcid":false,"given":"Yvonne N.","family":"Fondufe-Mittendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"3636_CR1","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1158\/1078-0432.CCR-08-1211","volume":"14","author":"OI Olopade","year":"2008","unstructured":"Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clin Cancer Res. 2008;14:7988\u201399.","journal-title":"Clin Cancer Res"},{"key":"3636_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","volume":"92","author":"A-M Martin","year":"2000","unstructured":"Martin A-M. Weber BL. Genetic and hormonal risk factors in breast cancer. J Natl Cancer Inst. 2000;92:1126\u201335.","journal-title":"J Natl Cancer Inst"},{"key":"3636_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-022-00363-1","volume":"12","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12:3.","journal-title":"Exp Hematol Oncol"},{"key":"3636_CR4","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Investig. 2011;121:3786\u20138.","journal-title":"J Clin Investig"},{"key":"3636_CR5","doi-asserted-by":"publisher","first-page":"1555.","DOI":"10.3390\/diagnostics11091555","volume":"11","author":"C Fumagalli","year":"2021","unstructured":"Fumagalli C, Barberis M. Breast cancer heterogeneity. Diagnostics. 2021;11:1555.","journal-title":"Diagnostics"},{"key":"3636_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","volume":"125","author":"F L\u00fc\u00f6nd","year":"2021","unstructured":"L\u00fc\u00f6nd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer. 2021;125:164\u201375.","journal-title":"Br J Cancer"},{"key":"3636_CR7","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271\u20137.","journal-title":"J Clin Oncol"},{"key":"3636_CR8","volume":"29","author":"AA Mohammed","year":"2021","unstructured":"Mohammed AA. The clinical behavior of different molecular subtypes of breast cancer. Cancer Treat Res Commun. 2021;29:100469.","journal-title":"Cancer Treat Res Commun"},{"key":"3636_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5152\/tjbh.2015.1669","volume":"11","author":"N Eliyatk\u0131n","year":"2015","unstructured":"Eliyatk\u0131n N, Yal\u00e7\u0131n E, Zengel B, Akta\u015f S, Vardar E. Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way. J Breast Health. 2015;11:59\u201366.","journal-title":"J Breast Health"},{"key":"3636_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jbi\/wbaa110","volume":"3","author":"KS Johnson","year":"2020","unstructured":"Johnson KS, Conant EF, Soo MS. Molecular subtypes of breast cancer: a review for breast radiologists. J Breast Imaging. 2020;3:12\u201324.","journal-title":"J Breast Imaging"},{"key":"3636_CR11","first-page":"85","volume":"8","author":"F Schettini","year":"2022","unstructured":"Schettini F, Bras\u00f3-Maristany F, Kuderer NM, Prat A. A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes. Nat Portf J Breast Cancer. 2022;8:85.","journal-title":"Nat Portf J Breast Cancer"},{"key":"3636_CR12","doi-asserted-by":"publisher","first-page":"2288.","DOI":"10.3390\/ijms23042288","volume":"23","author":"KH Lau","year":"2022","unstructured":"Lau KH, Tan AM, Shi Y. New and emerging targeted therapies for advanced breast cancer. Int J Mol Sci. 2022;23:2288.","journal-title":"Int J Mol Sci"},{"key":"3636_CR13","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/s41591-024-03060-0","volume":"30","author":"T Mukohara","year":"2024","unstructured":"Mukohara T, Park YH, Sommerhalder D, Yonemori K, Hamilton E, Kim S-B, et al. Inhibition of lysine acetyltransferase KAT6 in ER+HER2\u2212 metastatic breast cancer: a phase 1 trial. Nat Med. 2024;30:2242\u201350.","journal-title":"Nat Med"},{"key":"3636_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01895-7","volume":"10","author":"W Huang","year":"2024","unstructured":"Huang W, Zhu Q, Shi Z, Tu Y, Li Q, Zheng W, et al. Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer. Cell Death Discov. 2024;10:143.","journal-title":"Cell Death Discov"},{"key":"3636_CR15","doi-asserted-by":"publisher","first-page":"7235.","DOI":"10.3390\/ijms24087235","volume":"24","author":"J Szczepanek","year":"2023","unstructured":"Szczepanek J, Skorupa M, Jarkiewicz-Tretyn J, Cybulski C, Tretyn A. Harnessing epigenetics for breast cancer therapy: the role of DNA methylation, histone modifications, and microRNA. Int J Mol Sci. 2023;24:7235.","journal-title":"Int J Mol Sci"},{"key":"3636_CR16","doi-asserted-by":"publisher","first-page":"1325615.","DOI":"10.3389\/fimmu.2023.1325615","volume":"14","author":"J Yin","year":"2024","unstructured":"Yin J, Gu T, Chaudhry N, Davidson NE, Huang Y. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. Front Immunol. (Review). 2024;14:1325615.","journal-title":"Front Immunol. (Review)"},{"key":"3636_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13428-2","volume":"12","author":"F Font-Clos","year":"2022","unstructured":"Font-Clos F, Zapperi S, La Porta CAM. Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment. Sci Rep. 2022;12:9651.","journal-title":"Sci Rep"},{"key":"3636_CR18","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41588-023-01507-7","volume":"55","author":"X Jin","year":"2023","unstructured":"Jin X, Zhou Y-F, Ma D, Zhao S, Lin C-J, Xiao Y, et al. Molecular classification of hormone receptor-positive HER2-negative breast cancer. Nat Genet. 2023;55:1696\u2013708.","journal-title":"Nat Genet"},{"key":"3636_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/jnci\/djx270","volume":"110","author":"LS Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van\u2019t Veer LJ, et al. Intratumor heterogeneity of the estrogen receptor and the long-term risk of fatal breast cancer. J Natl Cancer Inst. 2018;110:726\u201333.","journal-title":"J Natl Cancer Inst"},{"key":"3636_CR20","first-page":"97","volume":"9","author":"L Beumers","year":"2023","unstructured":"Beumers L, Vlachavas E-I, Borgoni S, Schwarzm\u00fcller L, Penso-Dolfin L, Michels BE, et al. Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets. Nat Portf J Breast Cancer. 2023;9:97.","journal-title":"Nat Portf J Breast Cancer"},{"key":"3636_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12:1786.","journal-title":"Nat Commun"},{"key":"3636_CR22","unstructured":"Hegazy YA, Dhahri H, El Osmani N, George S, Chandler DP, Fondufe-Mittendorf YN. Histone variants: the bricks that fit differently. J Biol Chem."},{"key":"3636_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/cc.9.2.10465","volume":"9","author":"A Svotelis","year":"2010","unstructured":"Svotelis A, G\u00e9vry N, Grondin G, Gaudreau L. H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle. 2010;9:364\u201370.","journal-title":"Cell Cycle"},{"key":"3636_CR24","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.2174\/092986710792231941","volume":"17","author":"D Rangasamy","year":"2010","unstructured":"Rangasamy D. Histone variant H2A.Z can serve as a new target for breast cancer therapy. Curr Med Chem. 2010;17:3155\u201361.","journal-title":"Curr Med Chem"},{"key":"3636_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/msb.2008.25","volume":"4","author":"S Hua","year":"2008","unstructured":"Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, et al. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol. 2008;4:188.","journal-title":"Mol Syst Biol"},{"key":"3636_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113897","volume":"43","author":"FR Palma","year":"2024","unstructured":"Palma FR, Coelho DR, Pulakanti K, Sakiyama MJ, Huang Y, Ogata FT, et al. Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance. Cell Rep. 2024;43:113897.","journal-title":"Cell Rep"},{"key":"3636_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ccell.2019.08.006","volume":"36","author":"AP Gomes","year":"2019","unstructured":"Gomes AP, Ilter D, Low V, Rosenzweig A, Shen ZJ, Schild T, et al. Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization. Cancer Cell. 2019;36:402\u201317.e413.","journal-title":"Cancer Cell"},{"key":"3636_CR28","doi-asserted-by":"publisher","first-page":"8399","DOI":"10.1093\/nar\/gkz547","volume":"47","author":"M Long","year":"2019","unstructured":"Long M, Sun X, Shi W, Yanru A, Leung STC, Ding D, et al. A novel histone H4 variant H4G regulates rDNA transcription in breast cancer. Nucleic Acids Res. 2019;47:8399\u2013409.","journal-title":"Nucleic Acids Res"},{"key":"3636_CR29","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1002\/jcp.29770","volume":"235","author":"MYH Pang","year":"2020","unstructured":"Pang MYH, Sun X, Ausi\u00f3 J, Ishibashi T. Histone H4 variant, H4G, drives ribosomal RNA transcription and breast cancer cell proliferation by loosening nucleolar chromatin structure. J Cell Physiol. 2020;235:9601\u20138.","journal-title":"J Cell Physiol"},{"key":"3636_CR30","doi-asserted-by":"publisher","unstructured":"Saintilnord WN, Hegazy YA, Chestnutt K, Eckstein M, Cassidy RN, Dhahri H, et al. Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.11.18.624207.","DOI":"10.1101\/2024.11.18.624207"},{"key":"3636_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02533-6","volume":"22","author":"C Wilks","year":"2021","unstructured":"Wilks C, Zheng SC, Chen FY, Charles R, Solomon B, Ling JP, et al. recount3: summaries and queries for large-scale RNA-seq expression and splicing. Genome Biol. 2021;22:323.","journal-title":"Genome Biol"},{"key":"3636_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2021.100067","volume":"1","author":"A Thennavan","year":"2021","unstructured":"Thennavan A, Beca F, Xia Y, Garcia-Recio S, Allison K, Collins LC, et al. Molecular analysis of TCGA breast cancer histologic types. Cell Genomics. 2021;1:100067.","journal-title":"Cell Genomics"},{"key":"3636_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3636_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13072-022-00467-2","volume":"15","author":"RL Seal","year":"2022","unstructured":"Seal RL, Denny P, Bruford EA, Gribkova AK, Landsman D, Marzluff WF, et al. A standardized nomenclature for mammalian histone genes. Epigenetics Chromatin. 2022;15:34.","journal-title":"Epigenetics Chromatin"},{"key":"3636_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13578-020-00415-1","volume":"10","author":"D Nandy","year":"2020","unstructured":"Nandy D, Rajam SM, Dutta D. A three layered histone epigenetics in breast cancer metastasis. Cell Biosci. 2020;10:52.","journal-title":"Cell Biosci"},{"key":"3636_CR36","doi-asserted-by":"publisher","first-page":"e26476.","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6:e26476.","journal-title":"Elife"},{"key":"3636_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17:174.","journal-title":"Genome Biol"},{"key":"3636_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"3636_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol. 2012;30:413\u201321.","journal-title":"Nat Biotechnol"},{"key":"3636_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-18","volume":"2","author":"H Mizuno","year":"2009","unstructured":"Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2:18.","journal-title":"BMC Med Genomics"},{"key":"3636_CR41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1046-2023(03)00032-X","volume":"30","author":"J Debnath","year":"2003","unstructured":"Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30:256\u201368.","journal-title":"Methods"},{"key":"3636_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10152","volume":"6","author":"M Bernier","year":"2015","unstructured":"Bernier M, Luo Y, Nwokelo KC, Goodwin M, Dreher SJ, Zhang P, et al. Linker histone H1 and H3K56 acetylation are antagonistic regulators of nucleosome dynamics. Nat Commun. 2015;6:10152.","journal-title":"Nat Commun"},{"key":"3636_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0076-6879(99)04003-3","volume":"304","author":"K Luger","year":"1999","unstructured":"Luger K, Rechsteiner TJ, Richmond TJ. Preparation of nucleosome core particle from recombinant histones. Methods Enzymol. 1999;304:3\u201319.","journal-title":"Methods Enzymol"},{"key":"3636_CR44","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/bi9525684","volume":"35","author":"PM Schwarz","year":"1996","unstructured":"Schwarz PM, Felthauser A, Fletcher TM, Hansen JC. Reversible oligonucleosome self-association: dependence on divalent cations and core histone tail domains. Biochemistry. 1996;35:4009\u201315.","journal-title":"Biochemistry"},{"key":"3636_CR45","doi-asserted-by":"publisher","first-page":"12711","DOI":"10.1073\/pnas.1106264108","volume":"108","author":"M Simon","year":"2011","unstructured":"Simon M, North JA, Shimko JC, Forties RA, Ferdinand MB, Manohar M, et al. Histone fold modifications control nucleosome unwrapping and disassembly. Proc Natl Acad Sci. 2011;108:12711\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"3636_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/978-1-4939-0888-2_34","volume":"1170","author":"MP Walkiewicz","year":"2014","unstructured":"Walkiewicz MP, Bui M, Qu\u00e9net D, Dalal Y. Tracking histone variant nucleosomes across the human cell cycle using biophysical, biochemical, and cytological analyses. Methods Mol Biol. 2014;1170:589\u2013615.","journal-title":"Methods Mol Biol"},{"key":"3636_CR47","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish A, Diekhans M, Jungreis I, Lagarde J, Loveland JE, Mudge JM, et al. GENCODE 2021. Nucleic Acids Res. 2021;49:D916\u2013d923.","journal-title":"Nucleic Acids Res"},{"key":"3636_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"3636_CR49","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"3636_CR50","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213\u20138.","journal-title":"Nat Methods"},{"key":"3636_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"3636_CR52","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"3636_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.","journal-title":"Genome Biol"},{"key":"3636_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP. The ENCODE blacklist: identification of problematic regions of the genome. Sci Rep. 2019;9:9354.","journal-title":"Sci Rep"},{"key":"3636_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392.","journal-title":"Brief Bioinform"},{"key":"3636_CR56","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang L-G, He Q-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382\u20133.","journal-title":"Bioinformatics"},{"key":"3636_CR57","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/bioinformatics\/btx373","volume":"33","author":"J Brown","year":"2017","unstructured":"Brown J, Pirrung M, McCue LA. FQC Dashboard: integrates FastQC results into a web-based, interactive, and extensible FASTQ quality control tool. Bioinformatics. 2017;33:3137\u20139.","journal-title":"Bioinformatics"},{"key":"3636_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"3636_CR59","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"3636_CR60","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"3636_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"3636_CR62","doi-asserted-by":"publisher","first-page":"5306.","DOI":"10.3390\/cancers14215306","volume":"14","author":"A Rocca","year":"2022","unstructured":"Rocca A, Braga L, Volpe MC, Maiocchi S, Generali D. The predictive and prognostic role of RAS-RAF-MEK-ERK pathway alterations in breast cancer: revision of the literature and comparison with the analysis of cancer genomic datasets. Cancers. 2022;14:5306.","journal-title":"Cancers"},{"key":"3636_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02260-0","volume":"20","author":"KA Hirko","year":"2022","unstructured":"Hirko KA, Rocque G, Reasor E, Taye A, Daly A, Cutress RI, et al. The impact of race and ethnicity in breast cancer-disparities and implications for precision oncology. BMC Med. 2022;20:72.","journal-title":"BMC Med"},{"key":"3636_CR64","first-page":"127","volume":"3","author":"VW Chen","year":"1994","unstructured":"Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol, Biomark Prev. 1994;3:127\u201335.","journal-title":"Cancer Epidemiol, Biomark Prev"},{"key":"3636_CR65","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10549-020-05727-x","volume":"182","author":"AK Tzikas","year":"2020","unstructured":"Tzikas AK, Nemes S, Linderholm BK. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Res Treat. 2020;182:643\u201354.","journal-title":"Breast Cancer Res Treat"},{"key":"3636_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106292","volume":"183","author":"G Ameya","year":"2023","unstructured":"Ameya G, Birri DJ. The molecular mechanisms of virus-induced human cancers. Microb Pathogenesis. 2023;183:106292.","journal-title":"Microb Pathogenesis"},{"key":"3636_CR67","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5501\/wjv.v2.i2.102","volume":"2","author":"S Avanzi","year":"2013","unstructured":"Avanzi S, Alvisi G, Ripalti A. How virus persistence can initiate the tumorigenesis process. World J Virol. 2013;2:102\u20139.","journal-title":"World J Virol"},{"key":"3636_CR68","doi-asserted-by":"publisher","first-page":"514.","DOI":"10.3390\/cancers10120514","volume":"10","author":"S Siddharth","year":"2018","unstructured":"Siddharth S, Sharma D. Racial disparity and triple-negative breast cancer in African-American women: a multifaceted affair between obesity, biology, and socioeconomic determinants. Cancers. 2018;10:514.","journal-title":"Cancers"},{"key":"3636_CR69","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","volume":"15","author":"EC Dietze","year":"2015","unstructured":"Dietze EC, Sistrunk C, Miranda-Carboni G, O\u2019Regan R, Seewaldt VL. Triple-negative breast cancer in african-american women: disparities versus biology. Nat Rev Cancer. 2015;15:248\u201354.","journal-title":"Nat Rev Cancer"},{"key":"3636_CR70","doi-asserted-by":"publisher","first-page":"e2335821","DOI":"10.1001\/jamanetworkopen.2023.35821","volume":"6","author":"M Ensenyat-Mendez","year":"2023","unstructured":"Ensenyat-Mendez M, Solivellas-Pieras M, Llin\u00e0s-Arias P, \u00cd\u00f1iguez-Mu\u00f1oz S, Baker JL, Marzese DM, et al. Epigenetic profiles of triple-negative breast cancers of African American and white females. JAMA Netw Open. 2023;6:e2335821\u2013e2335821.","journal-title":"JAMA Netw Open"},{"key":"3636_CR71","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tibs.2020.12.012","volume":"46","author":"M Ghoneim","year":"2021","unstructured":"Ghoneim M, Fuchs HA, Musselman CA. Histone tail conformations: a fuzzy affair with DNA. Trends Biochem Sci. 2021;46:564\u201378.","journal-title":"Trends Biochem Sci"},{"key":"3636_CR72","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.fob.2013.08.007","volume":"3","author":"W Iwasaki","year":"2013","unstructured":"Iwasaki W, Miya Y, Horikoshi N, Osakabe A, Taguchi H, Tachiwana H, et al. Contribution of histone N-terminal tails to the structure and stability of nucleosomes. FEBS Open Bio. 2013;3:363\u20139.","journal-title":"FEBS Open Bio"},{"key":"3636_CR73","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1093\/emboj\/20.22.6383","volume":"20","author":"AE de la Barre","year":"2001","unstructured":"de la Barre AE, Angelov D, Molla A, Dimitrov S. The N-terminus of histone H2B, but not that of histone H3 or its phosphorylation, is essential for chromosome condensation. EMBO J. 2001;20:6383\u201393.","journal-title":"EMBO J"},{"key":"3636_CR74","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.jmb.2013.02.026","volume":"425","author":"T Nikitina","year":"2013","unstructured":"Nikitina T, Wang D, Gomberg M, Grigoryev SA, Zhurkin VB. Combined micrococcal nuclease and exonuclease III digestion reveals precise positions of the nucleosome core\/linker junctions: implications for high-resolution nucleosome mapping. J Mol Biol. 2013;425:1946\u201360.","journal-title":"J Mol Biol"},{"key":"3636_CR75","doi-asserted-by":"crossref","unstructured":"Eun H-M. 3 - Nucleases. In: Eun H-M, editor. Enzymology primer for recombinant DNA technology. San Diego: Academic Press; 1996. p. 145\u2013232.","DOI":"10.1016\/B978-012243740-3\/50006-5"},{"key":"3636_CR76","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1101\/gr.150482.112","volume":"23","author":"DR Winter","year":"2013","unstructured":"Winter DR, Song L, Mukherjee S, Furey TS, Crawford GE. DNase-seq predicts regions of rotational nucleosome stability across diverse human cell types. Genome Res. 2013;23:1118\u201329.","journal-title":"Genome Res"},{"key":"3636_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/srep33186","volume":"6","author":"C Riedmann","year":"2016","unstructured":"Riedmann C, Fondufe-Mittendorf YN. Comparative analysis of linker histone H1, MeCP2, and HMGD1 on nucleosome stability and target site accessibility. Sci Rep. 2016;6:33186.","journal-title":"Sci Rep"},{"key":"3636_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66259-4","volume":"10","author":"D Spakman","year":"2020","unstructured":"Spakman D, King GA, Peterman EJG, Wuite GJL. Constructing arrays of nucleosome positioning sequences using Gibson Assembly for single-molecule studies. Sci Rep. 2020;10:9903.","journal-title":"Sci Rep"},{"key":"3636_CR79","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/ol.2023.14107","volume":"26","author":"SY Park","year":"2023","unstructured":"Park SY, Eum DY, Jin Y, Lee CY, Shim JW, Choi SH, et al. Downregulation of complement factor H attenuates the stemness of MDA\u2011MB\u2011231 breast cancer cells via modulation of the ERK and p38 signaling pathways. Oncol Lett. 2023;26:521.","journal-title":"Oncol Lett"},{"key":"3636_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1731135","volume":"9","author":"KI Smolag","year":"2020","unstructured":"Smolag KI, Mueni CM, Leandersson K, Jirstr\u00f6m K, Hagerling C, M\u00f6rgelin M, et al. Complement inhibitor factor H expressed by breast cancer cells differentiates CD14(+) human monocytes into immunosuppressive macrophages. Oncoimmunology. 2020;9:1731135.","journal-title":"Oncoimmunology"},{"key":"3636_CR81","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-022-06635-y","volume":"194","author":"F Sato","year":"2022","unstructured":"Sato F, Sagara A, Tajima K, Miura S, Inaba K, Ando Y, et al. COL8A1 facilitates the growth of triple-negative breast cancer via FAK\/Src activation. Breast Cancer Res Treat. 2022;194:243\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"3636_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01465-8","volume":"20","author":"W Peng","year":"2020","unstructured":"Peng W, Li JD, Zeng JJ, Zou XP, Tang D, Tang W, et al. Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis. Cancer Cell Int. 2020;20:392.","journal-title":"Cancer Cell Int"},{"key":"3636_CR83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbrc.2022.12.046","volume":"642","author":"A Sagara","year":"2023","unstructured":"Sagara A, Miura S, Kobinata A, Naganawa R, Yaginuma S, Saito S, et al. COL8A1 enhances the invasion\/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression. Biochem Biophys Res Commun. 2023;642:145\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"3636_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2599","volume":"12","author":"C Cadenas","year":"2010","unstructured":"Cadenas C, Franckenstein D, Schmidt M, Gehrmann M, Hermes M, Geppert B, et al. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res. 2010;12:R44.","journal-title":"Breast Cancer Res"},{"key":"3636_CR85","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1073\/pnas.1406259111","volume":"111","author":"M Giordano","year":"2014","unstructured":"Giordano M, Roncagalli R, Bourdely P, Chasson L, Buferne M, Yamasaki S, et al. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc Natl Acad Sci. 2014;111:11115\u201320.","journal-title":"Proc Natl Acad Sci"},{"key":"3636_CR86","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s13287-022-03176-5","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Yang L, Chen X, Chen X, Diao L, Zeng Y, et al. TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities. Stem Cell Res Ther. 2022;13:479.","journal-title":"Stem Cell Res Ther"},{"key":"3636_CR87","first-page":"840","volume":"44","author":"P Feliciano","year":"2012","unstructured":"Feliciano P. CXCL1 and CXCL2 link metastasis and chemoresistance. Nat Genet. 2012;44:840\u2013840.","journal-title":"Nat Genet"},{"key":"3636_CR88","doi-asserted-by":"crossref","unstructured":"SenGupta S, Hein LE, Xu Y, Zhang J, Konwerski JR, Li Y, et al. Triple-negative breast cancer cells recruit neutrophils by secreting TGF-\u03b2 and CXCR2 ligands. Front Immunol. (Original Research) 2021;12.","DOI":"10.3389\/fimmu.2021.659996"},{"key":"3636_CR89","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12079-019-00508-8","volume":"13","author":"SJ Liao","year":"2019","unstructured":"Liao SJ, Luo J, Li D, Zhou YH, Yan B, Wei JJ, et al. TGF-\u03b21 and TNF-\u03b1 synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation. J Cell Commun Signal. 2019;13:369\u201380.","journal-title":"J Cell Commun Signal"},{"key":"3636_CR90","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-10-4554","volume":"71","author":"MK Asiedu","year":"2011","unstructured":"Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL. TGFbeta\/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011;71:4707\u201319.","journal-title":"Cancer Res"},{"key":"3636_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12307-011-0080-9","volume":"5","author":"LA Borthwick","year":"2012","unstructured":"Borthwick LA, Gardner A, De Soyza A, Mann DA, Fisher AJ. Transforming growth factor-\u03b21 (TGF-\u03b21) driven epithelial to mesenchymal transition (EMT) is accentuated by tumour necrosis factor \u03b1 (TNF\u03b1) via crosstalk between the SMAD and NF-\u03baB pathways. Cancer Microenviron. 2012;5:45\u201357.","journal-title":"Cancer Microenviron"},{"key":"3636_CR92","doi-asserted-by":"publisher","first-page":"48471","DOI":"10.18632\/oncotarget.17265","volume":"8","author":"M Maziveyi","year":"2017","unstructured":"Maziveyi M, Alahari SK. Cell matrix adhesions in cancer: the proteins that form the glue. Oncotarget. 2017;8:48471\u201387.","journal-title":"Oncotarget"},{"key":"3636_CR93","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms20102505","volume":"20","author":"IC Salaroglio","year":"2019","unstructured":"Salaroglio IC, Mungo E, Gazzano E, Kopecka J, Riganti C. ERK is a pivotal player of chemo-immune-resistance in cancer. Int J Mol Sci. 2019;20:2505.","journal-title":"Int J Mol Sci"},{"key":"3636_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.931774","volume":"12","author":"TY Avery","year":"2022","unstructured":"Avery TY, K\u00f6hler N, Zeiser R, Brummer T, Ruess DA. Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation. Front Oncol. 2022;12:931774.","journal-title":"Front Oncol"},{"key":"3636_CR95","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00432-021-03812-2","volume":"148","author":"S Arnold","year":"2022","unstructured":"Arnold S, Kortland J, Maltseva DV, Nersisyan SA, Samatov TR, Lezius S, et al. Fra-2 overexpression upregulates pro-metastatic cell-adhesion molecules, promotes pulmonary metastasis, and reduces survival in a spontaneous xenograft model of human breast cancer. J Cancer Res Clin Oncol. 2022;148:1525\u201342.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3636_CR96","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1158\/0008-5472.SABCS-2058","volume":"69","author":"C Schroeder","year":"2009","unstructured":"Schroeder C, Janke S, Krenkel S, Streichert T, Jaenicke F, Milde-Langosch K. Upregulation of Fra-1 and Fra-2 in breast cancer cells results in changes in adhesion, migration, invasion and stem cell markers. Cancer Res. 2009;69:2058\u20132058.","journal-title":"Cancer Res"},{"key":"3636_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1166-4","volume":"21","author":"G Kallergi","year":"2019","unstructured":"Kallergi G, Tsintari V, Sfakianakis S, Bei E, Lagoudaki E, Koutsopoulos A, et al. The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization. Breast Cancer Res. 2019;21:86.","journal-title":"Breast Cancer Res"},{"key":"3636_CR98","first-page":"217","volume":"7","author":"JM Kyriakis","year":"1999","unstructured":"Kyriakis JM. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr. 1999;7:217\u201331.","journal-title":"Gene Expr"},{"key":"3636_CR99","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9797929","volume":"2022","author":"PB Bhosale","year":"2022","unstructured":"Bhosale PB, Kim HH, Abusaliya A, Vetrivel P, Ha SE, Park MY, et al. Structural and functional properties of activator protein-1 in cancer and inflammation. Evid Based Complementary Alternative Med. 2022;2022:9797929.","journal-title":"Evid Based Complementary Alternative Med"},{"key":"3636_CR100","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, Ostendorf BN, Kerner Z, Tavazoie SF. Neuronal substance P drives metastasis through an extracellular RNA\u2013TLR7 axis. Nature. 2024;633:207\u201315.","journal-title":"Nature"},{"key":"3636_CR101","doi-asserted-by":"publisher","first-page":"14949","DOI":"10.1073\/pnas.96.26.14949","volume":"96","author":"A Glick","year":"1999","unstructured":"Glick A, Popescu N, Alexander V, Ueno H, Bottinger E, Yuspa SH. Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes. Proc Natl Acad Sci. 1999;96:14949\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"3636_CR102","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.celrep.2016.11.022","volume":"17","author":"V Comaills","year":"2016","unstructured":"Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, et al. Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition. Cell Rep. 2016;17:2632\u201347.","journal-title":"Cell Rep"},{"key":"3636_CR103","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","volume":"19","author":"X Guo","year":"2009","unstructured":"Guo X, Wang X-F. Signaling cross-talk between TGF-\u03b2\/BMP and other pathways. Cell Res. 2009;19:71\u201388.","journal-title":"Cell Res"},{"key":"3636_CR104","first-page":"955","volume":"1","author":"T Kamata","year":"2011","unstructured":"Kamata T, Pritchard C. Mechanisms of aneuploidy induction by RAS and RAF oncogenes. Am J Cancer Res. 2011;1:955\u201371.","journal-title":"Am J Cancer Res"},{"key":"3636_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","volume":"8","author":"DA Lukow","year":"2022","unstructured":"Lukow DA, Sheltzer JM. Chromosomal instability and aneuploidy as causes of cancer drug resistance. Trends Cancer. 2022;8:43\u201353.","journal-title":"Trends Cancer"},{"key":"3636_CR106","doi-asserted-by":"publisher","first-page":"30566","DOI":"10.1073\/pnas.2009506117","volume":"117","author":"JM Replogle","year":"2020","unstructured":"Replogle JM, Zhou W, Amaro AE, McFarland JM, Villalobos-Ortiz M, Ryan J, et al. Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division. Proc Natl Acad Sci. 2020;117:30566\u201376.","journal-title":"Proc Natl Acad Sci"},{"key":"3636_CR107","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/geno.2002.6850","volume":"80","author":"WF Marzluff","year":"2002","unstructured":"Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ. The human and mouse replication-dependent histone genes. Genomics. 2002;80:487\u201398.","journal-title":"Genomics"},{"key":"3636_CR108","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ceb.2005.04.010","volume":"17","author":"WF Marzluff","year":"2005","unstructured":"Marzluff WF. Metazoan replication-dependent histone mRNAs: a distinct set of RNA polymerase II transcripts. Curr Opin Cell Biol. 2005;17:274\u201380.","journal-title":"Curr Opin Cell Biol"},{"key":"3636_CR109","doi-asserted-by":"publisher","first-page":"e63745","DOI":"10.1371\/journal.pone.0063745","volume":"8","author":"V Kari","year":"2013","unstructured":"Kari V, Karpiuk O, Tieg B, Kriegs M, Dikomey E, Krebber H, et al. A subset of histone H2B genes produces polyadenylated mRNAs under a variety of cellular conditions. PLoS One. 2013;8:e63745.","journal-title":"PLoS One"},{"key":"3636_CR110","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1093\/nar\/gkw418","volume":"44","author":"SM Lyons","year":"2016","unstructured":"Lyons SM, Cunningham CH, Welch JD, Groh B, Guo AY, Wei B, et al. A subset of replication-dependent histone mRNAs are expressed as polyadenylated RNAs in terminally differentiated tissues. Nucleic Acids Res. 2016;44:9190\u2013205.","journal-title":"Nucleic Acids Res"},{"key":"3636_CR111","doi-asserted-by":"publisher","first-page":"msac019.","DOI":"10.1093\/molbev\/msac019","volume":"39","author":"P Raman","year":"2022","unstructured":"Raman P, Rominger MC, Young JM, Molaro A, Tsukiyama T, Malik HS. Novel classes and evolutionary turnover of histone H2B variants in the mammalian germline. Mol Biol Evol. 2022;39:msac019.","journal-title":"Mol Biol Evol"},{"key":"3636_CR112","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13072-015-0006-8","volume":"8","author":"RC Molden","year":"2015","unstructured":"Molden RC, Bhanu NV, LeRoy G, Arnaudo AM, Garcia BA. Multi-faceted quantitative proteomics analysis of histone H2B isoforms and their modifications. Epigenetics Chromatin. 2015;8:15.","journal-title":"Epigenetics Chromatin"},{"key":"3636_CR113","doi-asserted-by":"publisher","first-page":"6788.","DOI":"10.3390\/ijms25126788","volume":"25","author":"H Dhahri","year":"2024","unstructured":"Dhahri H, Saintilnord WN, Chandler D, Fondufe-Mittendorf YN. Beyond the usual suspects: examining the role of understudied histone variants in breast cancer. Int J Mol Sci. 2024;25:6788.","journal-title":"Int J Mol Sci"},{"key":"3636_CR114","first-page":"4893","volume":"18","author":"W Xie","year":"2019","unstructured":"Xie W, Zhang J, Zhong P, Qin S, Zhang H, Fan X, et al. Expression and potential prognostic value of histone family gene signature in breast cancer. Exp Ther Med. 2019;18:4893\u2013903.","journal-title":"Exp Ther Med"},{"key":"3636_CR115","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.molcel.2007.01.019","volume":"25","author":"A Jamai","year":"2007","unstructured":"Jamai A, Imoberdorf RM, Strubin M. Continuous histone H2B and transcription-dependent histone H3 exchange in yeast cells outside of replication. Mol Cell. 2007;25:345\u201355.","journal-title":"Mol Cell"},{"key":"3636_CR116","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s42003-021-01707-z","volume":"4","author":"R Hirano","year":"2021","unstructured":"Hirano R, Arimura Y, Kujirai T, Shibata M, Okuda A, Morishima K, et al. Histone variant H2A.B-H2B dimers are spontaneously exchanged with canonical H2A-H2B in the nucleosome. Commun Biol. 2021;4:191.","journal-title":"Commun Biol"},{"key":"3636_CR117","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-019-1038-1","volume":"567","author":"BA Nacev","year":"2019","unstructured":"Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, et al. The expanding landscape of \u2018oncohistone\u2019 mutations in human cancers. Nature. 2019;567:473\u20138.","journal-title":"Nature"},{"key":"3636_CR118","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41589-021-00738-1","volume":"17","author":"JD Bagert","year":"2021","unstructured":"Bagert JD, Mitchener MM, Patriotis AL, Dul BE, Wojcik F, Nacev BA, et al. Oncohistone mutations enhance chromatin remodeling and alter cell fates. Nat Chem Biol. 2021;17:403\u201311.","journal-title":"Nat Chem Biol"},{"key":"3636_CR119","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science. 2013;340:857\u201361.","journal-title":"Science"},{"key":"3636_CR120","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.aac7272","volume":"352","author":"C Lu","year":"2016","unstructured":"Lu C, Jain SU, Hoelper D, Bechet D, Molden RC, Ran L, et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science. 2016;352:844\u20139.","journal-title":"Science"},{"key":"3636_CR121","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/2159-8290.CD-19-0393","volume":"9","author":"RL Bennett","year":"2019","unstructured":"Bennett RL, Bele A, Small EC, Will CM, Nabet B, Oyer JA, et al. A mutation in histone H2B represents a new class of oncogenic driver. Cancer Discov. 2019;9:1438\u201351.","journal-title":"Cancer Discov"},{"key":"3636_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49486-5","volume":"15","author":"BA Nacev","year":"2024","unstructured":"Nacev BA, Dabas Y, Paul MR, Pacheco C, Mitchener M, Perez Y, et al. Cancer-associated histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. Nat Commun. 2024;15:5155.","journal-title":"Nat Commun"},{"key":"3636_CR123","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773:1263\u201384.","journal-title":"Biochim Biophys Acta"},{"key":"3636_CR124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1006491619920","volume":"62","author":"FC von Lintig","year":"2000","unstructured":"von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. Ras activation in human breast cancer. Breast Cancer Res Treat. 2000;62:51\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"3636_CR125","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0960-0760(01)00189-3","volume":"80","author":"RJ Santen","year":"2002","unstructured":"Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, et al. The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol. 2002;80:239\u201356.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3636_CR126","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/2159-8290.CD-18-1321","volume":"9","author":"R Yaeger","year":"2019","unstructured":"Yaeger R, Corcoran RB. Targeting alterations in the RAF-MEK pathway. Cancer Discov. 2019;9:329\u2013341.","journal-title":"Cancer Discov"},{"key":"3636_CR127","first-page":"1106","volume":"2","author":"CG Cremers","year":"2019","unstructured":"Cremers CG, Nguyen LK. Network rewiring, adaptive resistance and combating strategies in breast cancer. Cancer Drug Resistance. 2019;2:1106\u201326.","journal-title":"Cancer Drug Resistance"},{"key":"3636_CR128","first-page":"e29-e46.","volume":"41","author":"EM Stringer-Reasor","year":"2021","unstructured":"Stringer-Reasor EM, Elkhanany A, Khoury K, Simon MA, Newman LA. Disparities in breast cancer associated with african american identity. Am Soc. Clin Oncol Educ Book. 2021;41:e29-e46.","journal-title":"Clin Oncol Educ Book"},{"key":"3636_CR129","first-page":"88","volume":"8","author":"M Marczyk","year":"2022","unstructured":"Marczyk M, Qing T, O\u2019Meara T, Yagahoobi V, Pelekanou V, Bai Y, et al. Tumor immune microenvironment of self-identified african american and non-african american triple negative breast cancer. Nat Portf J Breast Cancer. 2022;8:88.","journal-title":"Nat Portf J Breast Cancer"},{"key":"3636_CR130","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/JCO.2015.63.7801","volume":"33","author":"BK Killelea","year":"2015","unstructured":"Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the national cancer data base. J Clin Oncol. 2015;33:4267\u201376.","journal-title":"J Clin Oncol"},{"key":"3636_CR131","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/jnci\/djp175","volume":"101","author":"KS Albain","year":"2009","unstructured":"Albain KS, Unger JM, Crowley JJ, Coltman CA Jr., Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009;101:984\u201392.","journal-title":"J Natl Cancer Inst"},{"key":"3636_CR132","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/cncr.22281","volume":"107","author":"WA Woodward","year":"2006","unstructured":"Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, et al. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer. 2006;107:2662\u20138.","journal-title":"Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03636-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:03:28Z","timestamp":1770116608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,2,24]]}},"alternative-id":["3636"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03636-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}